FASPX | JVMCX | FASPX / JVMCX | |
Total Expense Ratio | 1.34 | 1.87 | 72% |
Annual Report Gross Expense Ratio | 1.34 | 1.88 | 71% |
Fund Existence | 39 years | 14 years | - |
Gain YTD | -15.680 | -8.498 | 185% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.84B | 19.5B | 9% |
Annual Yield % from dividends | 0.43 | 0.00 | - |
Returns for 1 year | -21.52 | -15.20 | 142% |
Returns for 3 years | -11.10 | -9.56 | 116% |
Returns for 5 years | 61.79 | 40.58 | 152% |
Returns for 10 years | -4.63 | 12.89 | -36% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MXI | 78.95 | 2.94 | +3.87% |
iShares Global Materials ETF | |||
FTXH | 24.04 | 0.47 | +1.99% |
First Trust Nasdaq Pharmaceuticals ETF | |||
GGN | 4.18 | 0.08 | +1.95% |
GAMCO Global Gold Natural Resources & Income Trust | |||
BBAX | 46.29 | 0.81 | +1.78% |
JPMorgan BetaBuilders Dev APAC ex-JpnETF | |||
BGLD | 20.94 | -0.14 | -0.66% |
FT Vest Gold Strategy Qt Buffer ETF |